德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06996 德琪医药-B

交易中 03-11 13:47:24

3.040

+0.040

+1.33%

最高3.080	最低2.850	成交量527.05万
今开2.950	昨收3.000	日振幅7.67%
总市值20.64亿	流通市值20.64亿	总股本6.79亿
成交额1,590万	换手率0.78%	流通股本6.79亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06996","market":"HK","secType":"STK","nameCN":"德琪医药-B","latestPrice":3.04,"timestamp":1741671915589,"preClose":3,"halted":0,"volume":5270500,"delay":0,"floatShares":679000000,"shares":679000000,"eps":-1.0119348631578946,"marketStatus":"交易中","change":0.04,"latestTime":"03-11 13:47:24","open":2.95,"high":3.08,"low":2.85,"amount":15900370,"amplitude":0.076667,"askPrice":3.05,"askSize":62500,"bidPrice":3.04,"bidSize":26000,"shortable":0,"etf":0,"ttmEps":-0.9189250252631579,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1741680600000},"marketStatusCode":2,"adr":0,"listingDate":1605801600000,"exchange":"SEHK","adjPreClose":3,"openAndCloseTimeList":[[1741656600000,1741665600000],[1741669200000,1741680000000]],"volumeRatio":1.226907,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06996","defaultTab":"news","newsList":[{"id":"2518405731","title":"德琪医药-B盘中异动 早盘快速下挫5.00%报2.850港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518405731","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518405731?lang=zh_cn&edition=full","pubTime":"2025-03-11 09:39","pubTimestamp":1741657188,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘09时39分，德琪医药-B股票出现波动，股价快速下跌5.00%。截至发稿，该股报2.850港元/股，成交量23.65万股，换手率0.03%，振幅3.33%。资金方面，该股资金流入26.9万港元，流出38.576万港元。德琪医药-B股票所在的药品行业中，整体跌幅为0.20%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311093948abf48a9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311093948abf48a9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1574","BK1191","BK1583"],"gpt_icon":0},{"id":"2518678446","title":"德琪医药-B(06996.HK)拟3月21日举行董事会会议批准年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2518678446","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518678446?lang=zh_cn&edition=full","pubTime":"2025-03-11 06:31","pubTimestamp":1741645867,"startTime":"0","endTime":"0","summary":"格隆汇3月11日丨德琪医药-B(06996.HK)宣布，公司将于2025年3月21日（星期五）举行董事会会议，藉以（其中包括）考虑并批准公司及其附属公司截至2024年12月31日止年度业绩及其发布。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/11063148643605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","06996","BK1583","BK1574"],"gpt_icon":0},{"id":"2517610596","title":"德琪医药-B03月07日遭主力抛售104万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517610596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517610596?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:17","pubTimestamp":1741335428,"startTime":"0","endTime":"0","summary":"03月07日, 德琪医药-B股价跌1.27%，报收3.11元，成交金额1318万元，换手率0.63%，振幅6.98%，量比0.45。德琪医药-B今日主力资金净流出104万元，连续3日净流出，上一交易日主力净流出49万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为33.33%，平均跌幅为8.96%。该股近5个交易日上涨24.90%，主力资金累计净流出104万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入211万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170956a263e110&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170956a263e110&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06996","BK1574","BK1191"],"gpt_icon":0},{"id":"2517990939","title":"港股异动 | 德琪医药-B(06996)涨超14% 公司计划加大AI药物研发投入 希维奥®在印度尼西亚获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2517990939","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517990939?lang=zh_cn&edition=full","pubTime":"2025-03-06 11:33","pubTimestamp":1741231981,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德琪医药-B涨超14%，该股年内累计涨幅达390%。截至发稿，涨14.18%，报3.22港元，成交额1496.4万港元。消息面上，德琪医药昨日宣布，印度尼西亚食品药品监督管理局已批准希维奥的新药上市申请。值得一提的是，今年2月，德琪医药宣布计划加大投入，整合资源成立专门的AI部门。据悉，公司早在2021年便以天使投资人身份投资杭州德睿智药AI药物发现平台，并借此战略性的切入了AI药物发现赛道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258407.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","BK1191","06996"],"gpt_icon":0},{"id":"2517597037","title":"德琪医药-B盘中异动 急速拉升5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517597037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517597037?lang=zh_cn&edition=full","pubTime":"2025-03-06 09:31","pubTimestamp":1741224694,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时31分，德琪医药-B股票出现异动，股价大幅上涨5.67%。德琪医药-B股票所在的药品行业中，整体涨幅为0.10%。其相关个股中，德琪医药-B、李氏大药厂、精优药业涨幅较大，振幅较大的相关个股有顺腾国际控股、李氏大药厂、德琪医药-B，振幅分别为11.54%、5.26%、4.26%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306093134989ddb3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306093134989ddb3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","06996","BK1191"],"gpt_icon":0},{"id":"2517688209","title":"港股异动 | 德琪医药-B(06996)盘中涨超12% 年内累涨逾3倍 希维奥新药上市申请在印尼获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2517688209","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517688209?lang=zh_cn&edition=full","pubTime":"2025-03-05 13:54","pubTimestamp":1741154052,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德琪医药-B盘中涨超12%，年内累计涨幅已超320%，截至发稿，涨9.92%，报2.77港元，成交额1684.13万港元。消息面上，德琪医药宣布，印尼食品药品监督管理局已批准希维奥用于3项适应症的新药上市申请。公司2月中旬宣布，自2025年3月1日起，希维奥获批纳入台湾全民健康保险。值得注意的是，德琪医药近日公布，公司计划加大投入，整合资源成立专门的AI部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","06996","BK1583","BK1191"],"gpt_icon":0},{"id":"2517959945","title":"德琪医药-B(06996)：希维奥®的新药上市申请获印度尼西亚食品药品监督管理局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2517959945","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517959945?lang=zh_cn&edition=full","pubTime":"2025-03-05 12:02","pubTimestamp":1741147360,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，印度尼西亚食品药品监督管理局(BPOM)已批准希维奥(塞利尼索片)用于三项适应症的新药上市申请(NDA)：(1)与硼替佐米和地塞米松联用，用于治疗既往接受过至少一种先前治疗的多发性骨髓瘤(MM)的成年患者;(2)联合地塞米松用于治疗既往接受过至少四次既往治疗且对至少两种蛋白酶体抑制剂(PI)、至少两种免疫调节剂(IMiD)、一种抗CD38单克隆","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德琪医药-B(06996)：希维奥®的新药上市申请获印度尼西亚食品药品监督管理局批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1574","BK1583","06996"],"gpt_icon":0},{"id":"2517326109","title":"德琪医药-B盘中异动 急速上涨5.16%报2.650港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517326109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517326109?lang=zh_cn&edition=full","pubTime":"2025-03-05 09:42","pubTimestamp":1741138923,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘09时42分，德琪医药-B股票出现波动，股价急速拉升5.16%。截至发稿，该股报2.650港元/股，成交量34.2万股，换手率0.05%，振幅3.97%。资金方面，该股资金流入52.9695万港元，流出23.464万港元。德琪医药-B股票所在的药品行业中，整体涨幅为0.13%。其相关个股中，兴科蓉医药、三生制药、联邦制药涨幅较大，振幅较大的相关个股有兴科蓉医药、三生制药、联邦制药，振幅分别为9.24%、7.23%、6.90%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305094203abe8afdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305094203abe8afdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06996","BK1574","BK1583"],"gpt_icon":0},{"id":"2516860694","title":"德琪医药-B盘中异动 快速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516860694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516860694?lang=zh_cn&edition=full","pubTime":"2025-03-04 09:37","pubTimestamp":1741052265,"startTime":"0","endTime":"0","summary":"2025年03月04日早盘09时37分，德琪医药-B股票出现异动，股价快速下跌5.14%。截至发稿，该股报2.400港元/股，成交量154.95万股，换手率0.23%，振幅5.14%。德琪医药-B股票所在的药品行业中，整体跌幅为0.11%。其相关个股中，天大药业、联康生物科技集团、中智药业涨幅较大，振幅较大的相关个股有德琪医药-B、四环医药、康龙化成，振幅分别为4.74%、3.39%、3.24%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304093745a25df966&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304093745a25df966&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","BK1583","06996"],"gpt_icon":0},{"id":"2516524714","title":"德琪医药-B盘中异动 早盘大幅下跌6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516524714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516524714?lang=zh_cn&edition=full","pubTime":"2025-03-03 09:35","pubTimestamp":1740965707,"startTime":"0","endTime":"0","summary":"2025年03月03日早盘09时35分，德琪医药-B股票出现异动，股价大幅跳水6.43%。德琪医药-B股票所在的药品行业中，整体跌幅为0.02%。其相关个股中，兆科眼科-B、远大医药、草姬集团涨幅较大，振幅较大的相关个股有德琪医药-B、兆科眼科-B、远大医药，振幅分别为7.23%、6.71%、4.37%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030309350798992827&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030309350798992827&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","BK1583","06996"],"gpt_icon":0},{"id":"2514366996","title":"德琪医药-B盘中异动 快速下挫5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514366996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514366996?lang=zh_cn&edition=full","pubTime":"2025-02-28 09:37","pubTimestamp":1740706637,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘09时37分，德琪医药-B股票出现异动，股价大幅下挫5.24%。德琪医药-B股票所在的药品行业中，整体跌幅为0.03%。其相关个股中，海王英特龙、三生制药、草姬集团涨幅较大，振幅较大的相关个股有开拓药业-B、德琪医药-B、艾美疫苗，振幅分别为8.33%、7.34%、4.95%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022809371898959aba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022809371898959aba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1574","BK1583","BK1191"],"gpt_icon":0},{"id":"2514819448","title":"德琪医药-B盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514819448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514819448?lang=zh_cn&edition=full","pubTime":"2025-02-27 09:36","pubTimestamp":1740620187,"startTime":"0","endTime":"0","summary":"2025年02月27日早盘09时36分，德琪医药-B股票出现波动，股价急速上涨5.20%。截至发稿，该股报2.630港元/股，成交量8.55万股，换手率0.01%，振幅4.00%。德琪医药-B股票所在的药品行业中，整体跌幅为0.02%。其相关个股中，开拓药业-B、德琪医药-B、艾美疫苗涨幅较大，振幅较大的相关个股有开拓药业-B、德琪医药-B、三生制药，振幅分别为5.13%、4.00%、3.79%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270936279631d54c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270936279631d54c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1191","06996"],"gpt_icon":0},{"id":"2514907917","title":"港股异动 | 德琪医药-B(06996)再涨超11% 月内股价累涨超2.1倍 公司计划加大AI药物研发投入","url":"https://stock-news.laohu8.com/highlight/detail?id=2514907917","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514907917?lang=zh_cn&edition=full","pubTime":"2025-02-26 11:46","pubTimestamp":1740541585,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德琪医药-B再涨超11%，月内股价累涨超2.1倍。截至发稿，涨11.26%，报2.47港元，成交额1051.4万港元。消息面上，德琪医药近日公布，公司计划加大投入，整合资源成立专门的AI部门。据悉，公司早在2021年便以天使投资人身份投资杭州德睿智药AI药物发现平台，并借此战略性的切入了AI药物发现赛道。希维奥将于3月1日起正式纳入台湾市场《全民健康保险用药品项表》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06996","BK1574","BK1583","BK1191"],"gpt_icon":0},{"id":"2514020969","title":"德琪医药-B盘中异动 早盘快速拉升5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514020969","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514020969?lang=zh_cn&edition=full","pubTime":"2025-02-26 09:47","pubTimestamp":1740534465,"startTime":"0","endTime":"0","summary":"2025年02月26日早盘09时47分，德琪医药-B股票出现异动，股价急速拉升5.86%。截至发稿，该股报2.350港元/股，成交量51.5万股，换手率0.08%，振幅6.76%。德琪医药-B股票所在的药品行业中，整体跌幅为0.01%。其相关个股中，三爱健康集团、华控康泰、德琪医药-B涨幅较大，振幅较大的相关个股有德琪医药-B、李氏大药厂、和黄医药，振幅分别为6.76%、4.03%、3.83%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260947459892d7ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260947459892d7ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1574","BK1583","BK1191"],"gpt_icon":0},{"id":"2514135054","title":"港股异动 | 德琪医药-B(06996)尾盘涨超5% 公司拟加大AI药物研发投入 希维奥新适应症此前纳入医保","url":"https://stock-news.laohu8.com/highlight/detail?id=2514135054","media":"智通财经网","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514135054?lang=zh_cn&edition=full","pubTime":"2025-02-25 15:38","pubTimestamp":1740469120,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德琪医药-B尾盘涨超5%，月内累计涨幅已达180%。截至发稿，涨4.69%，报2.23港元，成交额1425.96万港元。消息面上，2月19日，德琪医药宣布，公司计划加大投入，整合资源成立专门的AI部门。希维奥在中国累积获批的两项适应症均已被纳入国家医保目录，医保覆盖人群进一步扩大。值得一提的是，希维奥在半年之内，实现了新适应症从获批、上市到纳入医保的“三级跳”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253957.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1583","06996","BK1574","BK1191"],"gpt_icon":0},{"id":"2514811260","title":"德琪医药-B盘中异动 早盘股价大跌6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514811260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514811260?lang=zh_cn&edition=full","pubTime":"2025-02-25 09:34","pubTimestamp":1740447253,"startTime":"0","endTime":"0","summary":"2025年02月25日早盘09时34分，德琪医药-B股票出现异动，股价大幅下跌6.10%。德琪医药-B股票所在的药品行业中，整体跌幅为0.24%。其相关个股中，联康生物科技集团、长江生命科技、海王英特龙涨幅较大，振幅较大的相关个股有德琪医药-B、联康生物科技集团、开拓药业-B，振幅分别为4.69%、3.08%、2.68%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225093413962f2876&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225093413962f2876&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","BK1583","06996"],"gpt_icon":0},{"id":"2513798486","title":"德琪医药-B盘中异动 股价大涨5.37%报2.160港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513798486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513798486?lang=zh_cn&edition=full","pubTime":"2025-02-24 09:46","pubTimestamp":1740361591,"startTime":"0","endTime":"0","summary":"2025年02月24日早盘09时46分，德琪医药-B股票出现波动，股价快速拉升5.37%。截至发稿，该股报2.160港元/股，成交量109.8万股，换手率0.16%，振幅6.34%。资金方面，该股资金流入137.82万港元，流出47.135万港元。德琪医药-B股票所在的药品行业中，整体跌幅为0.20%。其相关个股中，联康生物科技集团、德琪医药-B、石药集团涨幅较大，振幅较大的相关个股有艾美疫苗、康龙化成、草姬集团，振幅分别为11.13%、6.97%、6.90%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502240946319890300b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502240946319890300b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06996","BK1191","BK1583"],"gpt_icon":0},{"id":"2513209257","title":"成立AI部门，部署DeepSeek，德琪医药2月21日涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513209257","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513209257?lang=zh_cn&edition=full","pubTime":"2025-02-21 17:56","pubTimestamp":1740131760,"startTime":"0","endTime":"0","summary":"PHPWord2月21日，德琪医药股价表现亮眼，收盘报2.05元/股，涨幅超9%，总市值达12.77亿元。如今，公司计划加大投入成立AI部门，本地部署DeepSeek，整合资源加速TCE平台后续管线研发，旨在通过特定算法和资料采集分析，筛选候选蛋白、锁定肿瘤抗原。德琪医药于2020年11月20日在港交所主板上市，发行价18.08港元。2024年上半年，德琪医药营收0.61亿元，亏损1.67亿元，2020至2023年度亏损额更高，分别亏损29.29亿元、6.56亿元、6.01亿元和5.81亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221175710962b30dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221175710962b30dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996"],"gpt_icon":0},{"id":"2513023468","title":"港股异动 | 德琪医药-B(06996)再涨超14% 月内累涨1.7倍 公司计划加大AI药物研发投入","url":"https://stock-news.laohu8.com/highlight/detail?id=2513023468","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513023468?lang=zh_cn&edition=full","pubTime":"2025-02-21 14:39","pubTimestamp":1740119952,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德琪医药-B(06996)再涨超14%，月内累计涨幅已超170%。截至发稿，涨14.36%，报2.15港元，成交额1359.83万港元。消息面上，德琪医药公布，公司计划加大投入，整合资源成立专门的AI部门。这一举措包括本地部署DeepSeek以加速具有空间位元阻遮蔽效应的T细胞衔接器（TCE）平台后续管线研发。据悉，公司早在2021年便以天使投资人身份投资杭州德睿智药AI药物发现平台，并借此战略性的切入了AI药物发现赛道。同时公司也已通过AI资料模型结合多组学分析，成功发现全新肝癌相关抗原(TAA)并将其开发为TCE候选药物进入临床前验证阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1252636.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06996","BK1583","BK1574","BK1191"],"gpt_icon":0},{"id":"2513923963","title":"德琪医药-B盘中异动 下午盘股价大涨5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513923963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513923963?lang=zh_cn&edition=full","pubTime":"2025-02-21 13:50","pubTimestamp":1740117004,"startTime":"0","endTime":"0","summary":"2025年02月21日下午盘13时50分，德琪医药-B股票出现波动，股价急速上涨5.85%。德琪医药-B股票所在的药品行业中，整体涨幅为0.57%。其相关个股中，衍生集团、联康生物科技集团、翰森制药涨幅较大，振幅较大的相关个股有华控康泰、开拓药业-B、德琪医药-B，振幅分别为14.29%、13.16%、10.11%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221135004a24e1c3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221135004a24e1c3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06996","BK1191","BK1583"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.antengene.com","stockEarnings":[{"period":"1week","weight":0.1858},{"period":"1month","weight":2.8961},{"period":"3month","weight":3.6154},{"period":"6month","weight":3.6154},{"period":"1year","weight":1.8037},{"period":"ytd","weight":3.6154}],"compareEarnings":[{"period":"1week","weight":0.0338},{"period":"1month","weight":0.1254},{"period":"3month","weight":0.1709},{"period":"6month","weight":0.3901},{"period":"1year","weight":0.4543},{"period":"ytd","weight":0.1856}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要从事生物科技产品的发现、开发、生产及商业化。该公司的主要产品包括用于治疗复发╱难治性多发性骨髓瘤、复发╱难治性弥漫大B细胞淋巴瘤和非小细胞肺癌的ATG-010(selinexor)及用于治疗肝细胞癌和非小细胞肺癌等多种适应症的ATG-008(onatasertib)。该公司主要在亚太地区开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.083349},{"month":2,"riseRate":0.2,"avgChangeRate":0.354616},{"month":3,"riseRate":0.4,"avgChangeRate":-0.031767},{"month":4,"riseRate":0.5,"avgChangeRate":-0.02339},{"month":5,"riseRate":0.5,"avgChangeRate":-0.047362},{"month":6,"riseRate":0.25,"avgChangeRate":-0.063163},{"month":7,"riseRate":0,"avgChangeRate":-0.201302},{"month":8,"riseRate":0.25,"avgChangeRate":-0.091947},{"month":9,"riseRate":0.25,"avgChangeRate":-0.038884},{"month":10,"riseRate":0.5,"avgChangeRate":0.098032},{"month":11,"riseRate":0.75,"avgChangeRate":0.10189},{"month":12,"riseRate":0.4,"avgChangeRate":0.02925}],"exchange":"SEHK","name":"德琪医药-B","nameEN":"ANTENGENE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.5","shortVersion":"4.31.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德琪医药-B,06996,德琪医药-B股票,德琪医药-B股票老虎,德琪医药-B股票老虎国际,德琪医药-B行情,德琪医药-B股票行情,德琪医药-B股价,德琪医药-B股市,德琪医药-B股票价格,德琪医药-B股票交易,德琪医药-B股票购买,德琪医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}